Benzinga | Aug 10, 2020 07:42AM EDT

Revolution Medicines Q2 EPS $(0.46) Up From $(4.85) YoY, Sales $10.03M Down From $12.28M YoY

Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(0.46) per share. This is a 90.52 percent increase over losses of $(4.85) per share from the same period last year. The company reported $10.03 million in sales this quarter. This is a 18.37 percent decrease over sales of $12.28 million the same period last year.